Koss Olinger Consulting LLC increased its holdings in Albemarle Co. (NYSE:ALB – Free Report) by 1.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,972 shares of the specialty chemicals company’s stock after acquiring an additional 319 shares during the period. Koss Olinger Consulting LLC’s holdings in Albemarle were worth $1,892,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of ALB. WFA Asset Management Corp purchased a new stake in Albemarle in the 1st quarter worth about $25,000. First Community Trust NA purchased a new stake in Albemarle in the 2nd quarter worth about $25,000. CVA Family Office LLC lifted its stake in Albemarle by 610.0% in the 2nd quarter. CVA Family Office LLC now owns 284 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 244 shares in the last quarter. First Financial Corp IN purchased a new stake in Albemarle in the 1st quarter worth about $32,000. Finally, ORG Partners LLC lifted its stake in Albemarle by 2,142.1% in the 2nd quarter. ORG Partners LLC now owns 426 shares of the specialty chemicals company’s stock worth $42,000 after acquiring an additional 407 shares in the last quarter. 92.87% of the stock is owned by hedge funds and other institutional investors.
Albemarle Price Performance
Shares of ALB stock opened at $95.14 on Monday. The stock has a 50 day moving average of $89.58 and a two-hundred day moving average of $102.90. The company has a current ratio of 2.67, a quick ratio of 1.75 and a debt-to-equity ratio of 0.38. Albemarle Co. has a 12 month low of $71.97 and a 12 month high of $153.54. The company has a market capitalization of $11.18 billion, a P/E ratio of 34.60, a P/E/G ratio of 13.81 and a beta of 1.54.
Wall Street Analyst Weigh In
ALB has been the topic of several research reports. Baird R W lowered Albemarle from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 5th. Hsbc Global Res raised Albemarle to a “hold” rating in a research report on Wednesday, July 17th. Citigroup dropped their target price on Albemarle from $137.00 to $100.00 and set a “neutral” rating on the stock in a research report on Friday, July 12th. Berenberg Bank lowered Albemarle from a “buy” rating to a “hold” rating and lowered their price objective for the company from $160.00 to $83.00 in a report on Wednesday, July 31st. Finally, Robert W. Baird lowered Albemarle from an “outperform” rating to a “neutral” rating and lowered their price objective for the company from $102.00 to $85.00 in a report on Monday, August 5th. Two analysts have rated the stock with a sell rating, fifteen have issued a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $117.60.
Read Our Latest Stock Analysis on ALB
Albemarle Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
See Also
- Five stocks we like better than Albemarle
- 5 discounted opportunities for dividend growth investors
- Boeing Stock: Should You Buy, Sell, or Hold Ahead of Earnings
- 3 Stocks to Consider Buying in October
- Is Uber the Real Winner After Tesla’s ‘We, Robot’ Flop?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Here’s Why AMD Can’t Catch Up Soon to NVIDIA’s AI
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.